fbpx
Wikipedia

Amy K. LeBlanc

Amy K. LeBlanc is an American veterinary oncologist and biologist researching animal modeling for development of new cancer drugs and imaging agents, and identification of imaging biomarkers, development and optimization of PET imaging hardware and imaging protocols. She is a senior scientist in the molecular imaging program and director of the Comparative Oncology Program at the National Cancer Institute. LeBlanc was previously an associate professor at the University of Tennessee College of Medicine and College of Veterinary Medicine.

Amy K. LeBlanc
Alma materMichigan State University (BS, DVM)
Scientific career
FieldsVeterinary oncology, cancer biology, comparative medicine
InstitutionsUniversity of Tennessee
National Cancer Institute

Education

LeBlanc graduated from Michigan State University with a B.S. and D.V.M. She completed a rotating internship in small animal medicine and surgery at Texas A&M University and a residency in companion animal oncology at Louisiana State University. She is board-certified by the American College of Veterinary Internal Medicine.[1]

Career and research

LeBlanc was an associate professor with tenure and director of translational research at the University of Tennessee College of Veterinary Medicine (CVM) and University of Tennessee College of Medicine. LeBlanc's group at the University of Tennessee published the first comprehensive studies describing molecular imaging of dogs and cats using PET-CT, focusing on the forward and back-translation of 18F-labelled radiopharmaceuticals.[1]

LeBlanc is a board-certified veterinary oncologist and senior scientist in the molecular imaging program at the National Cancer Institute (NCI). She is director of the NCI's Comparative Oncology Program. Her research focus is in animal modeling for development of new cancer drugs and imaging agents, and identification of imaging biomarkers, development and optimization of PET imaging hardware and imaging protocols. In her position, she oversees and manages the operations of the Comparative Oncology Trials Consortium (COTC), which designs and executes clinical trials of new cancer therapies in tumor-bearing pet dogs.[1][2]

References

  1. ^ a b c "Amy K. LeBlanc, D.V.M." Center for Cancer Research. 2015-06-10. Retrieved 2020-10-11.  This article incorporates text from this source, which is in the public domain.
  2. ^ "Principal Investigators". NIH Intramural Research Program. Retrieved 2020-10-11.  This article incorporates text from this source, which is in the public domain.
  This article incorporates public domain material from websites or documents of the National Institutes of Health.

leblanc, american, veterinary, oncologist, biologist, researching, animal, modeling, development, cancer, drugs, imaging, agents, identification, imaging, biomarkers, development, optimization, imaging, hardware, imaging, protocols, senior, scientist, molecula. Amy K LeBlanc is an American veterinary oncologist and biologist researching animal modeling for development of new cancer drugs and imaging agents and identification of imaging biomarkers development and optimization of PET imaging hardware and imaging protocols She is a senior scientist in the molecular imaging program and director of the Comparative Oncology Program at the National Cancer Institute LeBlanc was previously an associate professor at the University of Tennessee College of Medicine and College of Veterinary Medicine Amy K LeBlancAlma materMichigan State University BS DVM Scientific careerFieldsVeterinary oncology cancer biology comparative medicineInstitutionsUniversity of TennesseeNational Cancer InstituteEducation EditLeBlanc graduated from Michigan State University with a B S and D V M She completed a rotating internship in small animal medicine and surgery at Texas A amp M University and a residency in companion animal oncology at Louisiana State University She is board certified by the American College of Veterinary Internal Medicine 1 Career and research EditLeBlanc was an associate professor with tenure and director of translational research at the University of Tennessee College of Veterinary Medicine CVM and University of Tennessee College of Medicine LeBlanc s group at the University of Tennessee published the first comprehensive studies describing molecular imaging of dogs and cats using PET CT focusing on the forward and back translation of 18F labelled radiopharmaceuticals 1 LeBlanc is a board certified veterinary oncologist and senior scientist in the molecular imaging program at the National Cancer Institute NCI She is director of the NCI s Comparative Oncology Program Her research focus is in animal modeling for development of new cancer drugs and imaging agents and identification of imaging biomarkers development and optimization of PET imaging hardware and imaging protocols In her position she oversees and manages the operations of the Comparative Oncology Trials Consortium COTC which designs and executes clinical trials of new cancer therapies in tumor bearing pet dogs 1 2 References Edit a b c Amy K LeBlanc D V M Center for Cancer Research 2015 06 10 Retrieved 2020 10 11 This article incorporates text from this source which is in the public domain Principal Investigators NIH Intramural Research Program Retrieved 2020 10 11 This article incorporates text from this source which is in the public domain This article incorporates public domain material from websites or documents of the National Institutes of Health Retrieved from https en wikipedia org w index php title Amy K LeBlanc amp oldid 1020232524, wikipedia, wiki, book, books, library,

article

, read, download, free, free download, mp3, video, mp4, 3gp, jpg, jpeg, gif, png, picture, music, song, movie, book, game, games.